Efficacy and Safety Study Comparing Respimat ® Budesonide With Turbohaler ® Budesonide in Symptomatic Adult Moderate to Severe Asthmatics Requiring Inhaled Corticosteroids and Bronchodilator Therapy

Condition:   Asthma
Interventions:   Drug: Respimat® Budesonide low dose;   Drug: Respimat® Budesonide high dose;   Drug: Turbohaler® Budesonide;   Drug: Placebo
Sponsor:   Boehringer Ingelheim
Completed – verified July 2014

View full post on ClinicalTrials.gov: asthma | received in the last 14 days

Chronic Dosing, Cross-Over Study to Assess the Efficacy and Safety of Budesonide (PT008) in Adult Subjects With Mild to Moderate Persistent Asthma

Condition:   Asthma
Interventions:   Drug: Budesonide Inhalation Aerosol (PT008) Dose 1;   Drug: Budesonide Inhalation Aerosol (PT008) Dose 2;   Drug: Budesonide Inhalation Aerosol (PT008) Dose 3;   Drug: Budesonide Inhalation Aerosol (PT008) Dose 4;   Drug: Placebo
Sponsor:   Pearl Therapeutics, Inc.
Not yet recruiting – verified April 2014

View full post on ClinicalTrials.gov: asthma | received in the last 14 days

Removing mold may reduce adult asthma risk – Reuters


Parent Herald

Removing mold may reduce adult asthma risk
Reuters
The more mold participants reported having seen in their homes, the greater their asthma symptoms, researchers found. Men were especially vulnerable with a four-fold increase in the odds of having non-allergic asthma after recent exposure to visible mold.
Mold exposure raises risk of adult asthmaParent Herald

all 10 news articles »

View full post on asthma – Google News

Study to Evaluate the Mastery of Inhaler Technique for Budesonide Formoterol (BF) SPIROMAX® as Compared to SYMBICORT® TURBOHALER® as Treatment for Adult Patients With Asthma

Condition:   Asthma
Interventions:   Drug: Budesonide and formoterol fumarate dehydrate (BF) SPIROMAX;   Drug: SYMBICORT TURBOHALER budesonide and formoterol fumarate
Sponsors:   Teva Pharmaceutical Industries;   Teva Branded Pharmaceutical Products, R&D Inc.
Not yet recruiting – verified February 2014

View full post on ClinicalTrials.gov: asthma | received in the last 14 days